Aimei Health Technology Co., Ltd Ordinary Share (AFJK) - Net Assets
Based on the latest financial reports, Aimei Health Technology Co., Ltd Ordinary Share (AFJK) has net assets worth $42.00 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($45.47 Million) and total liabilities ($3.46 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Aimei Health Technology Co., Ltd Ordinar (AFJK) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $42.00 Million |
| % of Total Assets | 92.38% |
| Annual Growth Rate | 3.65% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Aimei Health Technology Co., Ltd Ordinary Share - Net Assets Trend (2023–2024)
This chart illustrates how Aimei Health Technology Co., Ltd Ordinary Share's net assets have evolved over time, based on quarterly financial data. Also explore AFJK total asset value for the complete picture of this company's asset base.
Annual Net Assets for Aimei Health Technology Co., Ltd Ordinary Share (2023–2024)
The table below shows the annual net assets of Aimei Health Technology Co., Ltd Ordinary Share from 2023 to 2024. For live valuation and market cap data, see market value of Aimei Health Technology Co., Ltd Ordinar.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $72.31 Million | +3.66% |
| 2023-12-31 | $69.76 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aimei Health Technology Co., Ltd Ordinary Share's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 134248600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $73.78 Million | 102.04% |
| Total Equity | $72.31 Million | 100.00% |
Aimei Health Technology Co., Ltd Ordinary Share Competitors by Market Cap
The table below lists competitors of Aimei Health Technology Co., Ltd Ordinary Share ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Athens Medical C.S.A.
AT:IATR
|
$163.93 Million |
|
Peoples Bancorp of North Carolina
NASDAQ:PEBK
|
$163.94 Million |
|
Jinzhou Port Co Ltd A
SHG:600190
|
$164.05 Million |
|
Invesco Trust For Inv Grade NY Munis
NYSE:VTN
|
$164.13 Million |
|
Shane Global Holding Inc
TW:8482
|
$163.71 Million |
|
Marti Technologies Inc.
NYSE:MRT
|
$163.71 Million |
|
Marti Technologies Inc.
NYSE MKT:MRT
|
$163.71 Million |
|
Chiang Mai Ram Medical Business Public Company Limited
BK:CMR
|
$163.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aimei Health Technology Co., Ltd Ordinary Share's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 69,755,724 to 72,307,939, a change of 2,552,215 (3.7%).
- Net income of 2,552,000 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.55 Million | +3.53% |
| Other Changes | $215.00 | +0.0% |
| Total Change | $- | 3.66% |
Book Value vs Market Value Analysis
This analysis compares Aimei Health Technology Co., Ltd Ordinary Share's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.76x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 5.98x to 5.76x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2023-12-31 | $7.73 | $46.18 | x |
| 2024-12-31 | $8.01 | $46.18 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aimei Health Technology Co., Ltd Ordinary Share utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.53%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.02x
- Recent ROE (3.53%) is above the historical average (1.89%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2023 | 0.25% | 0.00% | 0.00x | 1.01x | $-6.80 Million |
| 2024 | 3.53% | 0.00% | 0.00x | 1.02x | $-4.68 Million |
Industry Comparison
This section compares Aimei Health Technology Co., Ltd Ordinary Share's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $119,229,142
- Average return on equity (ROE) among peers: 3.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aimei Health Technology Co., Ltd Ordinary Share (AFJK) | $42.00 Million | 0.25% | 0.08x | $163.82 Million |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $214.29 Million | 0.06% | 0.07x | $230.18 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $265.09 Million |
| Ares Acquisition Corporation II (AACT) | $952.33 Million | 0.00% | 0.06x | $587.05 Million |
| AA Mission Acquisition Corp. (AAM) | $-468.10 Million | 0.00% | 0.00x | $409.92K |
| Altenergy Acquisition Corp (AEAE) | $4.84 Million | 51.14% | 2.71x | $72.25 Million |
| Activate Energy Acquisition Corp. Class A Ordinary Share (AEAQ) | $223.53 Million | 0.00% | 0.04x | $235.74 Million |
| Aifeex Nexus Acquisition Corporation (AIFE) | $86.16 Million | -0.10% | 0.01x | $91.13 Million |
| AI TRANSPORTATION ACQUISITION CORP Ordinary shares (AITR) | $60.04 Million | -0.06% | 0.02x | $86.22 Million |
| Alchemy Investments Acquisition Corp 1 Class A Ordinary Shares (ALCY) | $41.25K | -21.21% | 8.88x | $49.57 Million |
About Aimei Health Technology Co., Ltd Ordinary Share
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other servic… Read more